Osteoprotegerin Before and After Periodontal Surgery
Launched by CAIRO UNIVERSITY · Jun 7, 2014
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
assessment of osteoprotegerin in patients with chronic periodontitis before and after periodontal surgery in gingival crevicular fluid, saliva and gingival tissues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • severe chronic periodontitis, having pocket depth of ≥ 5 mm and clinical attachment level ≥ 5 mm
- Exclusion Criteria:
- • pregnant women
- • subjects had \<22 permanent teeth
- • having any given systemic disease
- • taking any type of medication and/or antibiotic therapy during the 3 months before the study
- • received periodontal treatment within the past 12 months
- • current or former smokers.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Mahmoud ElRefai, M.D.
Study Director
Professor of Oral Medicine and Periodontology , Faculty of oral and dental medicine Cairo Unv.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials